Michael Krekler
About Michael Krekler
Michael Krekler is the Medical Director Cardiovascular & Metabolics at Bristol-Myers Squibb in Munich, Germany, with over 30 years of experience at the company.
Title
Michael Krekler is the Medical Director of Cardiovascular & Metabolics at Bristol-Myers Squibb. He currently operates in the Munich Area, Germany.
Current Role at Bristol-Myers Squibb
Michael Krekler serves as the Medical Director Cardiovascular & Metabolics at Bristol-Myers Squibb. He is responsible for leading the medical strategies and overseeing the development and implementation of cardiovascular and metabolic therapeutic areas. His role involves collaborating with various stakeholders, ensuring compliance with medical regulations, and spearheading clinical initiatives within these specialized fields. He is based in the Munich Area, Germany.
Previous Positions at Bristol-Myers Squibb
Michael Krekler has held multiple key positions at Bristol-Myers Squibb over his extensive 30-year tenure. Notably, he served as European Medical Lead Irbesartan for 8 months in 2002 and as Medical Director Cardiovascular & Hypertension for 5 years from 2001 to 2006. He also held roles as European Medical Lead Omapatrilat (2000-2001), Senior Medical Advisor Hypertension (1998-2000), Clinical Trial Manager (1991-1998), and Medical Advisor Metabolics Pravastatin (1989-1991). Throughout these roles, he has consistently demonstrated his expertise in cardiovascular and metabolic fields.
Education and Expertise
Michael Krekler completed his Master's Degree in Pharmacy at Johannes Gutenberg-Universität Mainz (1989-1993). He also holds a Doctor of Philosophy (Ph.D.) in Pharmacology from Heinrich-Heine-Universität Düsseldorf (1985-1988). His educational background laid a strong foundation for his extensive career in the medical field. He has developed deep expertise in cardiovascular, hypertension, and metabolics management, evidenced by his varied roles and responsibilities at Bristol-Myers Squibb over several decades.
Background in Clinical Trials
Michael Krekler has significant experience in managing clinical trials, having served as Clinical Trial Manager at Bristol-Myers Squibb for 7 years from 1991 to 1998. His role involved designing, implementing, and overseeing clinical trials to ensure they met stringent regulatory standards. This experience has been instrumental in shaping his strategic approach to medical management and therapeutic development in cardiovascular and metabolic diseases.